# Hopman Mark: insider transactions

SEC CIK 2048497. Roles and transactions as reported on Form 4. Latest Form 4 filed 2026-10-28.

## Roles

| Company | Role | Transactions | First | Latest |
| --- | --- | ---: | --- | --- |
| [Beta Bionics, Inc.](/companies/bbnx.md) | Chief Commercial Officer, Officer | 1 | 2026-10-26 | 2026-10-26 |

## Transactions: 1

Every transaction reported, newest first. Codes P and S are open-market purchases and sales. Reported price is as stated on the form.

| Date | Company | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-26 | [Beta Bionics, Inc.](/companies/bbnx.md) | Sale (S) | 821 | $20.00 | $16.4k | [Form 4](/filings/0002048497-26-000023.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 30, 2026, 14:21 ET. No prices; not investment advice.